The Board of Directors of Nanjing Vazyme Biotech Co., Ltd. has authorized a buyback plan on August 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.24 CNY | +0.33% | -4.60% | -24.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.30% | 1.33B | |
+37.74% | 723B | |
+34.49% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.99% | 244B | |
+10.03% | 208B | |
-4.17% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- 688105 Stock
- News Nanjing Vazyme Biotech Co.,Ltd
- Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.